Elevation Spine Closes $11 Million Financing

Elevation Spine Saber-C Spinal Fusion Implant

Elevation Spine completed its Series B Preferred Stock financing, totaling $11 million.

Proceeds will support increased commercial production of Saber-C® spinal fusion technology, as well as development of future product extensions of the company’s Saber Technology platform of products.

Charles Gilbride, CEO of Elevation Spine, said, “This...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0